P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma.
作者信息
Lee Yu Rim, Park Soo Young
机构信息
Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.
出版信息
Clin Mol Hepatol. 2015 Sep;21(3):230-1. doi: 10.3350/cmh.2015.21.3.230. Epub 2015 Sep 30.
Abstract
摘要
相似文献
1
P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma.P53在肝细胞癌中的表达：对肝细胞癌放射治疗反应的影响。
Clin Mol Hepatol. 2015 Sep;21(3):230-1. doi: 10.3350/cmh.2015.21.3.230. Epub 2015 Sep 30.
2
Influence of P53 on the radiotherapy response of hepatocellular carcinoma.P53对肝细胞癌放疗反应的影响。
Clin Mol Hepatol. 2015 Sep;21(3):257-67. doi: 10.3350/cmh.2015.21.3.257. Epub 2015 Sep 30.
3
Tumor suppressor p53 response is blunted by low-dose radiation.肿瘤抑制因子p53的反应会因低剂量辐射而减弱。
Phys Med. 2001;17 Suppl 1:215-6.
4
5
Proton induces apoptosis of hypoxic tumor cells by the p53-dependent and p38/JNK MAPK signaling pathways.质子通过p53依赖和p38/JNK丝裂原活化蛋白激酶信号通路诱导缺氧肿瘤细胞凋亡。
Int J Oncol. 2008 Dec;33(6):1247-56.
6
p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis.γ射线辐射诱导人胶质瘤细胞凋亡过程中p53非依赖性神经酰胺的形成
Cell Death Differ. 2004 Aug;11(8):853-61. doi: 10.1038/sj.cdd.4401428.
7
Apoptotic cell death in erythrocytes of p53-deficient medaka (Oryzias latipes) after γ-irradiation.γ射线照射后p53基因缺失的青鳉（Oryzias latipes）红细胞中的凋亡性细胞死亡。
Int J Radiat Biol. 2016 Oct;92(10):572-6. doi: 10.1080/09553002.2016.1222091. Epub 2016 Sep 1.
8
[Apoptosis and gamma rays].[细胞凋亡与伽马射线]
Ann Pharm Fr. 1999 Jul;57(4):314-23.
9
10
Cell proliferation index and the expression of p53 and Bcl-2 in tumorous and non-tumorous lesions of hepatocellular carcinoma and metastatic liver cancer.细胞增殖指数以及p53和Bcl-2在肝细胞癌和转移性肝癌肿瘤及非肿瘤病变中的表达。
Yonsei Med J. 1998 Oct;39(5):424-9. doi: 10.3349/ymj.1998.39.5.424.
引用本文的文献
1
An Efficient 5-Aminolevulinic Acid Photodynamic Therapy Treatment for Human Hepatocellular Carcinoma.一种高效的 5-氨基酮戊酸光动力疗法治疗人肝癌。
Int J Mol Sci. 2023 Jun 21;24(13):10426. doi: 10.3390/ijms241310426.
2
Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse.肝癌药物反应和复发中的核糖核苷酸还原酶亚基转换。
Commun Biol. 2023 Mar 8;6(1):249. doi: 10.1038/s42003-023-04630-7.
3
Alpinumisoflavone Impairs Mitochondrial Respiration via Oxidative Stress and MAPK/PI3K Regulation in Hepatocellular Carcinoma Cells.高山槐黄酮通过氧化应激和丝裂原活化蛋白激酶/磷脂酰肌醇-3-激酶调控损害肝癌细胞的线粒体呼吸
Antioxidants (Basel). 2022 Sep 28;11(10):1929. doi: 10.3390/antiox11101929.
4
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer.嵌合 HDAC 和细胞骨架抑制剂 broxbam 作为肝癌的一种新的治疗策略。
Int J Oncol. 2022 Jun;60(6). doi: 10.3892/ijo.2022.5363. Epub 2022 Apr 29.
5
In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma.溶液或脂质体形式的阿霉素的体外细胞毒性和细胞内摄取：对肝细胞癌治疗的影响。
Cells. 2021 Jul 6;10(7):1717. doi: 10.3390/cells10071717.
6
Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine.NDRG2 和 LDHA 的联合异常表达预测肝细胞癌预后并介导吉西他滨的抗肿瘤作用。
Int J Biol Sci. 2019 Jul 3;15(9):1771-1786. doi: 10.7150/ijbs.35094. eCollection 2019.
7
Entrainment of superoxide rhythm by menadione in HCT116 colon cancer cells.甲萘醌诱导 HCT116 结肠癌细胞中超氧阴离子的节律产生。
Sci Rep. 2019 Mar 4;9(1):3347. doi: 10.1038/s41598-019-40017-7.
8
Krüppel-like factor 2 inhibits hepatocarcinogenesis through negative regulation of the Hedgehog pathway.Krüppel 样因子 2 通过负向调控 Hedgehog 通路抑制肝癌发生。
Cancer Sci. 2019 Apr;110(4):1220-1231. doi: 10.1111/cas.13961. Epub 2019 Mar 4.
9
CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma.CMA通过降解HMGB1蛋白下调p53表达，以抑制辐射引发的肝癌细胞凋亡。
World J Gastroenterol. 2017 Apr 7;23(13):2308-2317. doi: 10.3748/wjg.v23.i13.2308.
本文引用的文献
1
Strategies to improve radiotherapy with targeted drugs.提高靶向药物放射治疗效果的策略。
Nat Rev Cancer. 2011 Apr;11(4):239-53. doi: 10.1038/nrc3007.
2
Radiation-induced intercellular signaling mediated by cytochrome-c via a p53-dependent pathway in hepatoma cells.辐射诱导的细胞间信号通过细胞色素 c 和 p53 依赖途径在肝癌细胞中的传递。
Oncogene. 2011 Apr 21;30(16):1947-55. doi: 10.1038/onc.2010.567. Epub 2010 Dec 6.
3
Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides.放射性核素经肝动脉介入治疗肝细胞癌。
Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):41-9. doi: 10.1038/nrgastro.2009.202.
4
The first 30 years of p53: growing ever more complex.p53的头30年：愈发复杂
Nat Rev Cancer. 2009 Oct;9(10):749-58. doi: 10.1038/nrc2723.
5
Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma.肝细胞癌门静脉瘤栓的适形放射治疗
Radiother Oncol. 2007 Sep;84(3):266-71. doi: 10.1016/j.radonc.2007.07.005. Epub 2007 Aug 22.
6
Repopulation of cancer cells during therapy: an important cause of treatment failure.治疗期间癌细胞的再增殖：治疗失败的一个重要原因。
Nat Rev Cancer. 2005 Jul;5(7):516-25. doi: 10.1038/nrc1650.
7
Hepatocellular carcinoma: the need for progress.肝细胞癌：取得进展的必要性。
J Clin Oncol. 2005 May 1;23(13):2892-9. doi: 10.1200/JCO.2005.03.196.
8
Treatment of Hepatocellular Carcinoma.肝细胞癌的治疗
Curr Treat Options Gastroenterol. 2003 Dec;6(6):465-472. doi: 10.1007/s11938-003-0048-z.
9
Radionuclide therapy of hepatocellular carcinoma.肝细胞癌的放射性核素治疗
Ann Acad Med Singap. 2003 Jul;32(4):518-24.
10
The role of p53 in determining sensitivity to radiotherapy.p53在决定放疗敏感性中的作用。
Nat Rev Cancer. 2003 Feb;3(2):117-29. doi: 10.1038/nrc992.
Zotero 插件